Search Within

Miguel-Angel Perales

Formats
  1. Meeting Abstract (498)
  2. Journal Article (361)
  3. Review (29)
  4. Research Letter (18)
  5. Guidelines (12)
  6. Book Section (10)
  7. Editorial (6)
  8. Correspondence (5)
  9. Book Whole (1)
  10. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (941)
  2. Center for Hematologic Malignancies (941)
  3. Department of Medicine (941)
  4. Hematologic Malignancies, Division of (941)
  5. Survivorship Research (473)
  6. CTCR Scholars (410)

More Groups

People
  1. Sergio Giralt (428)
  2. Sean Devlin (302)
  3. Ann Jakubowski (247)
  4. Esperanza Papadopoulos (237)
  5. Gunjan Shah (203)
  6. Molly Maloy (196)

More People

Years
  1. 2025 (29)
  2. 2024 (76)
  3. 2023 (101)
  4. 2022 (95)
  5. 2021 (68)
  6. 2020 (93)

More Years

Publications
  1. Blood (263)
  2. Biology of Blood and Marrow Transplantation (220)
  3. Bone Marrow Transplantation (86)
  4. Transplantation and Cellular Therapy (68)
  5. Blood Advances (46)
  6. Journal of Clinical Oncology (32)

More Publications

Publishers
  1. American Society of Hematology (311)
  2. Elsevier Inc. (302)
  3. Nature Publishing Group (112)
  4. American Society of Clinical Oncology (32)
  5. Oxford University Press (18)
  6. John Wiley & Sons (17)

More Publishers

Results (941)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lactose drives Enterococcus expansion to promote graft-versus-host disease
    Journal Article

    Stein-Thoeringer, C. K.; Nichols, K. B.; Lazrak, A.; Docampo, M. D.; Slingerland, A. E.; Slingerland, J. B.; Clurman, A. G.; Armijo, G.; Gomes, A. L. C.; Shono, Y.; more...
    Science (2019)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cell therapy for cancer and heart
    Review

    Ganatra, S.; Carver, J. R.; Hayek, S. S.; Ky, B.; Leja, M. J.; Lenihan, D. J.; Lenneman, C.; Mousavi, N.; Park, J. H.; Perales, M. A.; more...
    Journal of the American College of Cardiology (2019)

    Fulltext@MSK | Save
  • Clinical utilization of chimeric antigen receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) - An expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
    Editorial

    Kansagra, A. J.; Frey, N. V.; Bar, M.; Laetsch, T. W.; Carpenter, P. A.; Savani, B. N.; Heslop, H. E.; Bollard, C. M.; Komanduri, K. V.; Gastineau, D. A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation in the treatment of adult acute lymphoblastic leukemia: Updated 2019 evidence-based review from The American Society for Transplantation and Cellular Therapy
    Guidelines

    DeFilipp, Z.; Advani, A. S.; Bachanova, V.; Cassaday, R. D.; Deangelo, D. J.; Kebriaei, P.; Rowe, J. M.; Seftel, M. D.; Stock, W.; Tallman, M. S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Inferior survival after microbiota injury: A multicenter alto-HCT study
    Meeting Abstract

    Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Littmann, E. R.; Taur, Y.; Sung, A. D.; Weber, D.; Hashimoto, D.; Wright, R. J.; Amoretti, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Impact of geriatric vulnerability on outcomes of older patients in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Flynn, J.; Jakubowski, A. A.; Shahrokni, A.; Dahi, P.; Perales, M. A.; Sanchez-Escamilla, M.; Tamari, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CMV outcomes and health care resource utilization in CMV-seropositive (R+) hematopoietic stem cell transplant (HCT) recipients managed with pre-emptive therapy (PET)
    Meeting Abstract

    Fang, J.; Zavras, P. D.; Su, Y.; Raval, A. D.; Tang, Y.; Perales, M. A.; Giralt, S.; Papanicolaou, G.
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • The SFGM-TC MDS score at day 180 is associated with post-transplant outcomes in patients with myelodysplastic syndrome who underwent CD34+ selected allogeneic stem cell transplant
    Meeting Abstract

    Alarcon, A.; Hilden, P. D.; Maloy, M.; Ruiz, J. D.; Sanchez-Escamilla, M.; Yañez, L.; Castillo, N.; Tamari, R.; Shaffer, B.; Castro-Malaspina, H.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease: 6-month follow-up data from the phase 2 REACH1 trial
    Meeting Abstract

    Jagasia, M.; Ali, H.; Schroeder, M. A.; Shah, N. N.; Chen, Y. B.; Dawkins, F.; Arbushites, M.; Tian, C.; Perales, M. A.
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • A phase II clinical trial of leuprolide for enhancement of immune reconstitution after ex vivo CD34+ cell-selected allogeneic HCT with TBI-based conditioning
    Meeting Abstract

    Cho, C.; Devlin, S. M.; Avecilla, S. T.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Maloy, M.; Maslak, P.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save